Lagergren J, Bergström R, Nyrén O
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
Ann Intern Med. 1999 Jun 1;130(11):883-90. doi: 10.7326/0003-4819-130-11-199906010-00003.
The incidence of esophageal and gastric cardia adenocarcinoma is, for unknown reasons, increasing dramatically. A weak and inconsistent association between body mass index (BMI) and adenocarcinoma of the esophagus and gastric cardia has been reported.
To reexamine the association between BMI and development of adenocarcinoma of the esophagus and gastric cardia.
Nationwide, population-based case-control study.
Sweden, 1995 through 1997.
Patients younger than 80 years of age who had recently received a diagnosis were eligible. Comprehensive organization ensured rapid case ascertainment. Controls were randomly selected from the continuously updated population register. Interviews were conducted with 189 patients with adenocarcinoma of the esophagus and 262 patients with adenocarcinoma of the gastric cardia; for comparison, 167 patients with incident esophageal squamous-cell carcinoma and 820 controls were also interviewed.
Odds ratios were determined from BMI and cancer case-control status. Odds ratios estimated the relative risk for the two adenocarcinomas studied and were calculated by multivariate logistic regression with adjustment for potential confounding factors.
A strong dose-dependent relation existed between BMI and esophageal adenocarcinoma. The adjusted odds ratio was 7.6 (95% CI, 3.8 to 15.2) among persons in the highest BMI quartile compared with persons in the lowest. Obese persons (persons with a BMI > 30 kg/m2) had an odds ratio of 16.2 (CI, 6.3 to 41.4) compared with the leanest persons (persons with a BMI < 22 kg/m2). The odds ratio for patients with cardia adenocarcinoma was 2.3 (CI, 1.5 to 3.6) in those in the highest BMI quartile compared with those in the lowest BMI quartile and 4.3 (CI, 2.1 to 8.7) among obese persons. Esophageal squamous-cell carcinoma was not associated with BMI.
The association between BMI and esophageal adenocarcinoma is strong and is not explained by bias or confounding. The carcinogenic mechanism, however, remains to be clarified. The increasing prevalence of obesity in western countries could be important in understanding the increasing occurrence of this tumor.
食管癌和贲门腺癌的发病率正急剧上升,原因不明。据报道,体重指数(BMI)与食管癌和贲门腺癌之间存在微弱且不一致的关联。
重新审视BMI与食管癌和贲门腺癌发生之间的关联。
基于全国人口的病例对照研究。
瑞典,1995年至1997年。
年龄小于80岁且近期确诊的患者符合条件。全面的组织确保了病例的快速确诊。对照从不断更新的人口登记册中随机选取。对189例食管癌患者和262例贲门腺癌患者进行了访谈;作为比较,还对167例初发食管鳞状细胞癌患者和820名对照进行了访谈。
根据BMI和癌症病例对照状态确定比值比。比值比估计了所研究的两种腺癌的相对风险,并通过多因素逻辑回归计算,对潜在混杂因素进行了调整。
BMI与食管腺癌之间存在强烈的剂量依赖性关系。与BMI最低四分位数人群相比,BMI最高四分位数人群的调整后比值比为7.6(95%CI,3.8至15.2)。肥胖者(BMI>30kg/m²)与最瘦者(BMI<22kg/m²)相比,比值比为16.2(CI,6.3至41.4)。与BMI最低四分位数人群相比,BMI最高四分位数的贲门腺癌患者的比值比为2.3(CI,1.5至3.6),肥胖者中的比值比为4.3(CI,2.1至8.7)。食管鳞状细胞癌与BMI无关。
BMI与食管腺癌之间的关联很强,且不能用偏倚或混杂来解释。然而,致癌机制仍有待阐明。西方国家肥胖患病率的上升可能对理解这种肿瘤发病率的增加具有重要意义。